Loblaw, a leading grocery retailer, reported an increase in profits for the second quarter, driven by strong performance in its discount chains No Frills and Maxi. The company highlighted significant sales growth in its pharmacy unit, attributing it to the increasing popularity of generic GLP-1 weight loss medications.
Based in Brampton, Ontario, Loblaw released its financial results for the quarter ending June 20, revealing a revenue surpassing $15.3 billion, marking a four percent rise from the previous quarter. The profit available to common shareholders also saw a notable increase, climbing around five percent to $751 million.
The company reported a 1.6 percent growth in same-store sales for its core retail food business, with its drug retail unit, including Shoppers Drug Mart, experiencing a 4.6 percent increase in same-store sales. The pharmacy and health-care services segment saw a substantial 7.5 percent rise, attributed to the growth in specialty prescriptions, particularly driven by the introduction of generic GLP-1 drugs.
During a conference call with analysts, Loblaw’s chief financial officer, Richard Dufresne, emphasized the positive impact of generic GLP-1 drugs on revenue and gross profit margins. The company anticipates continued growth due to higher volumes despite lower generic drug pricing.
The GLP-1 drug category, which includes brands like Ozemic and Wegovy, has seen a significant uptick in sales, with a reported 40 percent increase year-to-date. Loblaw executives noted the growing trend in the prior quarter.
CEO Per Bank highlighted a shift in consumer behavior towards frozen vegetables over fresh produce due to inflationary pressures, with a notable increase in sales at No Frills and Maxi stores. The company remains focused on providing value to customers amid food price inflation, with a strong position in the market.
Despite inflationary challenges, Loblaw continues to perform well, gaining market share in hard discount segments and surpassing competitors in conventional retail. The company’s internal food inflation metrics remain favorable compared to the national grocery CPI.
Recent data from Statistics Canada indicated a decrease in the inflation rate to 2.8 percent in June, with grocery price increases moderating to 3.9 percent from 4.3 percent in May. Loblaw’s Toronto-listed shares traded steadily on Thursday, reflecting a year-to-date gain of approximately six percent.